March 19, 2020 / 6:57 PM / 13 days ago

BRIEF-FDA Approves New Treatment For Pediatric Patients With Any Strain Of Hepatitis C

March 19 (Reuters) - FDA:

* FDA APPROVES NEW TREATMENT FOR PEDIATRIC PATIENTS WITH ANY STRAIN OF HEPATITIS C

* FDA - GRANTED PRIORITY REVIEW OF EPCLUSA TO GILEAD SCIENCES INC

* FDA - EPCLUSA IN COMBINATION WITH RIBAVIRIN INDICATED TO TREAT PEDIATRIC PATIENTS 6 YRS & OLDER OR WEIGHING AT LEAST 37 POUNDS WITH SEVERE CIRRHOSIS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below